title: Lens GABA receptors are a target of GABA-related agonists that mitigate experimental myopia.
abstract: Coordinated growth of eye tissues is required to achieve visual acuity. However, visual experience also guides this process. Experimental myopia can be produced by altering light entering the eye, but also by changing light/dark regimens. Drug discovery studies demonstrated that γ-aminobutyric acid (GABA)-related agonists (e.g., baclofen) will mitigate experimental myopia, and are also drugs studied for their capacity to affect neurodevelopmental disorders that include Fragile X Syndrome and related autism spectrum disorders. GABA receptors thought to mediate these responses in the eye have been studied in the neural retina as well as the cornea and sclera which are both innervated tissues. In addition to neurons, lenses express GAD25/65/67 GABA metabolic enzymes and at least 13 GABA receptor subunits with developmental expression profiles that match neural development. Evidence that lens GABA receptors are expressed in a cell environment comparable to neurons is seen in the lens expression of AMPA and NMDA glutamate receptors together with an unexpectedly comprehensive array of associated signaling proteins that include post-synaptic-density 95 (PSD95), calcium calmodulin kinase IIα (CaMKIIα), Fragile X Syndrome mental retardation protein (FMRP), ephrin receptors, Ca(V)1.2, 1.3 channels, cyclin-dependent kinase 5 (Cdk5), and neuronal C-src among others. Moreover, lens cells share fundamental molecular regulatory mechanisms that integrate the regulation and function of these genes at the DNA, RNA, and protein levels in neurons. GABA has trophic, growth promoting effects early in neuron development and later assumes its classic inhibitory role in the adult neural system. We hypothesize that the extensive parallels between GABA and glutamate receptor biology in lens and brain identifies the lens as a site of GABA agonist drug action affecting experimental myopia, acting through lens GABA receptors to similarly affect growth in both elongated cell types.
authors.affiliation: Department of Oral Biology, Rutgers SDM and BHS, New Jersey, Newark, NJ 07103, USA; Department of Pharmacology & Physiology, Rutgers SDM and BHS, New Jersey, Newark, NJ 07103, USA. Electronic address: frederph@sdm.rutgers.edu.
authors.forename: Peter H
authors.initials: PH
authors.lastname: Frederikse
authors.affiliation: Department of Oral Biology, Rutgers SDM and BHS, New Jersey, Newark, NJ 07103, USA.
authors.forename: Chinnaswamy
authors.initials: C
authors.lastname: Kasinathan
mesh_terms: D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D018755:GABA Agonists / Q000494:pharmacology*; D020869:Gene Expression Profiling; D007908:Lens, Crystalline / Q000378:metabolism*; D051379:Mice; D008954:Models, Biological; D009216:Myopia / Q000188:drug therapy*; D018079:Receptors, GABA / Q000378:metabolism*; D017470:Receptors, Glutamate / Q000378:metabolism
chemical_list: D018755:GABA Agonists; D018079:Receptors, GABA; D017470:Receptors, Glutamate; D001418:Baclofen